Quick Answer
JRSIS HEALTH CARE Corp reported R&D Expense of $189.3 thousand for fiscal year 2023.
JRSIS HEALTH CARE Corp R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2023 | $189.3K | -33.1% |
| 2022 | $283.0K | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2024 | $28.8K | -20.3% | +200.4% |
| June 30, 2024 | $9.6K | -75.0% | -6.4% |
| March 31, 2024 | $10.3K | -66.2% | -71.7% |
| September 30, 2023 | $36.2K | — | -5.6% |
| June 30, 2023 | $38.3K | — | +26.6% |
| March 31, 2023 | $30.3K | — | — |
- JRSIS HEALTH CARE Corp showed a decrease of -33.1% in R&D Expense compared to the prior fiscal year.
- Over the 2022–2023 period, JRSIS HEALTH CARE Corp’s r&d expense has declined by 33.1% (from $283.0 thousand to $189.3 thousand).
- The most recent figure is from JRSIS HEALTH CARE Corp’s fiscal year 2023 report (Form 10-K), filed with the SEC on April 26, 2024.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: